July 24, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the market. The availability of a robust healthcare infrastructure and favorable reimbursement policies ...
April 21, 2026
According to market projections, the global epigenetic antibodies market, valued at USD 2.29 billion in 2024, is anticipated to reach USD 12.01 billion by 2034, growing at a CAGR of 18.04% over the next decade.The epigenetic antibodies market is growing due to their role in many diseases, like cancer, autoimmune diseases, and psychiatric disorders....
April 21, 2026
Market insights predict the global cellular health screening industry will increase from USD 3.37 billion in 2024 to USD 8.14 billion by 2034, achieving a CAGR of 9.24%. The rising prevalence of chronic disorders and technological advancements drive the global market. Whereas, the presence of a robust healthcare infrastructure and increasing invest...
April 21, 2026
Market insights predict, the breast cancer screening tests industry is expected to grow from USD 4.44 billion in 2024 to USD 8.77 billion by 2034, driven by a CAGR of 7.04%. The breast cancer screening tests market is growing due to its major applications, including mammography, breast ultrasound, breast MRI, clinical breast examination (CBE), brea...
April 21, 2026
Based on market forecasts, the live cell imaging sector will expand from USD 2.92 billion in 2024 to USD 6.49 billion by 2034, experiencing a CAGR of 8.34%.The live cell imaging market is growing due to this imaging allows researchers to observe and document the behaviour of living cells over time, offering a dynamic standpoint on cellular processe...
April 21, 2026
Based on market forecasts, the breast cancer liquid biopsy sector will expand from USD 229.6 million in 2025 to USD 912.83 million by 2035, experiencing a CAGR of 14.8%. Breast cancer cases are rising day by day, which is increasing the demand for biopsy, leading to the significant growth of the breast cancer liquid biopsy market. North America is ...
April 21, 2026
Based on market forecasts, the interventional radiology sector will expand from USD 30.74 billion in 2024 to USD 60.82 billion by 2034, experiencing a CAGR of 7.17%.The interventional radiology market’s growth is attributed to the rising incidences of cardiovascular diseases and cancer. At the same time, North America is the dominant region d...
April 21, 2026
Market insights predict the global in vitro release testing (IVRT) industry will increase from USD 65.55 million in 2024 to USD 252.64 million by 2034, achieving a CAGR of 14.47%.The market is growing due to rising demand for bioequivalent testing in generic and topical formulations. Regulatory pressure for accurate, non-clinical drug evaluation ...
April 21, 2026
Based on market forecasts, the pleural biopsy sector will expand from USD 329.03 million in 2024 to USD 594.6 million by 2034, experiencing a CAGR of 6.14%. The pleural biopsy market is expanding due to rising demand for pleural diagnostics as well as increasing use of video-assisted thoracoscopic surgery. North America led the market due to the ...
April 21, 2026
Market insights predict the global liquid biopsy IVD industry will increase from USD 2.21 billion in 2024 to USD 8.72 billion by 2034, achieving a CAGR of 14.79%. The liquid biopsy IBD market is growing due to the rising cases of cancer. North America is leading the market due to the focus on early diagnosis to prevent healthcare complications an...
+1 804 441 9344
+65 3106 5601 or +91 87933 22019
